Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema

NCT01823081 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Intravitreal injection of bevacizumab (Avastin)
DRUG: Intravitreal injection of fasudil and bevacizumab (Avastin)

Sponsor

Shahid Beheshti University of Medical Sciences